Coverage And Compliance of Mass Drug Administration for Elimination of Lymphatic Filariasis in Endemic Areas of Sagar and Damoh Districts, Madhya Pradesh
Keywords:
Mass drug administration, Lymphatic filariasis, Diethylcarbamazine, Coverage, complianceAbstract
Background: Lymphatic filariasis (LF) is one of the oldest and most debilitating of the neglected tropical diseases. An estimated 120 million people in 73 endemic countries are currently infected with LF, 53 countries are implementing MDA to interrupt transmission. The mass drug administration (MDA) with single dose of diethylcarbamazine (DEC) was carried out for the eligible population in Sagar and Damoh district of Madhya Pradesh to eliminate LF.
Objective: To asses programme in terms of coverage and compliance of MDA against filariasis, reasons for non compliance in Sagar and Damoh district of Madhya Pradesh.
Material and Method: A community based cross-sectional survey was conducted in Sagar and Damoh district of MP. A total of eight clusters, one urban and three rural clusters were selected in each district. The data were collected in pretested Performa and analyzed.
Results: The study includes 240 families with a total eligible population was 1155 in two districts of eight clusters. The compliance rate were 85.52% in Sagar, 42.82% in Damoh district and total compliance was 66.66% observed by us which was below the expected target .The important cause of non compliance was drug distributor not asked to take drug in front of him 50% and in 23% did not received drug or not present at home at the time of drug distribution.
Conclusion: There is urgent need to strengthen MDA programme implementation and effective drug delivery strategies which increase compliance of drug.
References
World Health Organization, Geneva. Global pro-gramme to eliminate lymphatic filariasis: progress re-port, 2011. Weekly Epidemiol Rec; WHO 2012, 87, p.346.
World Health Organization, Geneva. Progress report 2000–2009 and strategic plan 2010–2020 global pro-gramme to eliminate lymphatic filariasis. WHO2010; p. ix.
World Health Organization, Regional Office for South-East Asia. The regional strategic plan for elimi-nation of lymphatic filariasis,2010–2015. WHO; 2010; p. 1-3.
Elimination of lymphatic filariaisis: Training manual on mass drug administration and morbidity man-agement. New Delhi: Directorate of National Vector Borne Disease Control Programme, Government of India 2009; p. 10–2.
National Health Policy 2002. New Delhi: Department of Health, Ministry of Health and Family Welfare, Government of India. Available at: http://www.fpload_b.nic.in/NRHM/documents/ National_Health_Policy_2002.pdf [accessed on 20 September 2010.
6. Operational guidelines on elimination of lymphatic qwfilariasis. Delhi: Directorate of National Vector Borne Disease Control Programme, Government of India 2004; p. 3.
Lymphatic filariasis: MDA Coverage since 2007,Microfilaria rate in state since 2004. Available at: http://www.nvbdcp.gov.in/filariasis-new.html. Accessed on Nov.10th, 2013.
Operational guidelines on elimination of lymphatic filariasis India. Available at: http://www.nvbdcp.gov.in/Doc/LF%20manual_final.doc. Accessed on April 15th 2012.
Lahariya Chandrakant, Mishra A. Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evalu-ation study. J Vector Borne Dis 2008; 45: 313–20.
Patel P.K. Mass drug administration coverage evalua-tion survey for lymphatic Filariasis in Bagalkot and Gulbarga districts. Indian J Community Med 2012;37(2):101-106.
Mukhopadhyay AK, Patnaik SK, Satya Babu P, Rao KNMB Knowledge on lymphatic filariasis and mass drug administration (MDA) programme in filaria en-demic districts of Andhra Pradesh, India. J Vector Borne Dis 2008; 45: 73–5.
Kumar P, Prajapati PB, Saxena D, Kavishwar AB, Kurian G. An evaluation of coverage and compliance of mass drug administration 2006 for elimination of lymphatic filariasis in endemic areas of Gujarat. Indi-an J Commun Med 2008; 33: 38–42.
Aswathy S, Beteena K, Leelamoni K. Mass drug ad-ministration against filariasis in India: perceptions and practices in a rural community in Kerala. Ann Trop Med Parasitol 2009: 103(7): 617–24.
Babu BV, Rath K, Kerketta AS, Swain BK, Mishra S, Kar SK. Adverse reactions following mass drug ad-ministration during the programme to eliminate lym-phatic filariasis in Orissa state, India. Trans R Soc Trop Med Hyg 2006; 100: 464–9.
Nirgude et al, “Evaluation Of Coverage And Compli-ance Of Mass Drug Administration Programme 2011 for Elimination of Lymphatic Filariasis In Nalgonda District of Andhra Pradesh, India” National Journal of Community Medicine 3 (2) April-June 2012, p 288-293.
Mahalakshmy T, Kalaiselvan G, Parmar J, Dongre A. Coverage and compliance to diethylcarbamazine in relation to Filaria Prevention Assistants in rural Puducherry, India. J Vector Borne Dis 2010; 47: 113–5.
Muralidhar M Kulkarni, Veena G Kamath, Sujatha K, Darshan B B, Varun N, Asha Coverage And Compli-ance Of Mass Drug Administration Programme Against Filariasis In Bijapur District, Karnataka J Pub Health Med Res 2013;1(1):1-4
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
The authors retain the copyright of their article, with first publication rights granted to Medsci Publications.
